Short Summary
The petitioner sought directions from the Delhi High Court regarding the high cost of the drug Zolgensma. The petitioner requested that the Union of India facilitate the issuance of compulsory licenses under the Patents Act, 1970, and also asked for the formation of a committee to raise funds for her treatment.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Miss Kiara Rawat Through Mrs. Lovely Gusain vs Union Of India & Ors. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Bristol-Myers Squibb CompanyvsMr.D. Shah
Bristol-Myers Squibb Company filed two suits seeking permanent injunctions and damages against Mr. D. Shah and others for infringing its Indian Patent No. 203937. The patent covers DASATINIB, an anti-cancer molecule used to treat chronic myeloid leukemia (CML). Given the defendants' admission of infringement and the risk of irreparable harm, the Delhi High Court allowed the injunction applications, maintaining the status quo during the trial.
Levi Strauss & Co.vsLalit Kumar Jaggia
Levi Strauss & Co. filed a suit against Lalit Kumar Jaggia seeking permanent injunctions due to the alleged infringement of its registered trademarks, including 'LEVI'S', 'Two Horse Logo', and associated designs, as well as copyright violation in its labels. The court found the defendant guilty of flagrant infringement and decreed the suit for permanent injunction along with awarding punitive damages.
Vidya Bhushan JainvsMohammed Younus Sheikh And Anr
The Delhi High Court disposed of a writ petition concerning Trademark No. 605340 after finding that the core issue had been resolved by the parties. The court noted that the trademark renewal process was completed, with the mark being renewed for another ten years. Consequently, the High Court set aside an earlier order from the Intellectual Property Appellate Board (IPAB) and allowed the petitioner's trademark to continue subsisting in the Register.
Rajesh Sultania And Anr.vsArun Kumar Murarka
The Delhi High Court dismissed a petition filed by Rajesh Sultania and Anr. which challenged the rejection of a plaint in an infringement suit brought by Arun Kumar Murarka. The Petitioners argued that the Respondent lacked standing to sue for trademark infringement because he was not the registered proprietor of 'YEH KHILA YEH KHILA.' However, the Court found that the comprehensive nature of the Respondent's claim—which included both copyright and trademark infringement—disclosed a valid cause of action. Furthermore, the court noted an assignment deed supporting the Respondent's ownership claims, concluding that the preliminary rejection of the plaint was correct.
Suncare Formulations Pvt. Ltd.vsOreo Healthcare
The plaintiffs, manufacturers of pharmaceutical products under the registered trademark 'HAEMOCAL', sued defendants for using the deceptively similar mark 'HEMOCAL' and copying their unique packaging and labeling. The court found that the marks were deceptively similar and likely to cause confusion among the public.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.